[ASAP] Development and Preclinical Assessment of a Palbociclib Nanostructured Lipid Carrier for Potential Breast Cancer Management 🔗 Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c01122 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
